A prospective study of tender points and fibromyalgia during and after an acute viral infection

Archives of Internal Medicine

Volumn 159, Issue 8, 1999, Pages 865-870

  Rea, Tom ^a   Russo, Joan ^b   Katon, Wayne ^b   Ashley, Rhoda L ^a   Buchwald, Dedra ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; FIBROMYALGIA; HIGH TEMPERATURE; HUMAN; INFECTIOUS MONONUCLEOSIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PAIN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RISK FACTOR; SOCIAL ADAPTATION;

ACUTE DISEASE; ADOLESCENT; ADULT; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VIRUS DISEASES;

EID: 0033606108     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.8.865     Document Type: Article

References (63)

1. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum. 1990;33:160-172.
2. Wolfe F. Fibromyalgia. Rheum Dis Clin North Am. 1990;16:681-698.
3. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38: 19-28.
4. Cathey MA, Wolfe F, Kleinheksel S, Hawley D. Socioeconomic impact of fibrositis. Am J Med. 1986;81(3A):78-84.
5. Reilly PA. Fibromyalgia in the workplace: a "management" problem. Ann Rheum Dis. 1993;52:249-251.
6. Pope A, Tarlov A. Disability in America: Toward a National Agenda for Prevention. Washington, DC: Institute of Medicine, National Academy Press; 1991.
7. Buchwald D. Fibromyalgia and chronic fatigue syndrome: similarities and differences. Rheum Dis Clin North Am. 1996;22:219-243.
8. Wolfe F, Anderson J, Harkness D, et al. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum. 1997;40: 1560-1570.
9. Wolfe F, Anderson J, Harkness D, et al. Work and disability status of persons with fibromyalgia. J Rheumatol. 1997;24:1171-1178.
10. Wolfe F, Anderson J, Harkness D, et al. Health status and disease severity in fibromyalgia. Arthritis Rheum. 1997;40:1571-1579.
11. Goldenberg DL. Psychiatric and psychologic aspects of fibromyalgia syndrome. Rheum Dis Clin North Am. 1989;15:106-114.
12. Russell IJ. Neurohormonal aspects of fibromyalgia syndrome. Rheum Dis Clin North Am. 1989;15:149-168.
13. Caro XJ. Is there an immunologic component to the fibrositis syndrome? Rheum Dis Clin North Am. 1989;15:169-186.
14. Moldofsky H, Scarisbrick P, England R, Smythe H. Musculoskeletal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med. 1975;37:341-351.
15. Bengtsson A, Henriksson KS. The muscle in fibromyalgia: a review of Swedish studies. J Rheumatol. 1989;16(suppl 19):144-149.
16. Moldofsky H. Sleep, neuroimmune and neuroendocrine functions in fibromyalgia and chronic fatigue syndrome. Adv Neuroimmunol. 1995;5:39-56.
17. Dinerman H, Steere A. Lyme disease associated with fibromyalgia. Ann Intern Med. 1992;117:281-285.
18. Simms RW, Zerbini CA, Ferrante N, Anthony J, Felson DT, Craven DE. Fibromyalgia syndrome in patients with the human immunodeficiency virus. Am J Med. 1992;92:368-374.
19. Buskila D, Dafna DG, Langevitz P, Urowitz S, Smythe HA. Fibromyalgia in human immunodeficiency virus infection. J Rheumatol. 1990;17:1202-1206.
20. Buskila D, Shnaider A, Neumann L, Zilberman D, Hilzenrat N, Sikuler E. Fibromyalgia in hepatitis C infection. Arch Intern Med. 1997;157:2497-2500.
21. Rivera J, de Diego A, Trinchet M, Garcia-Monforte A. Fibromyalgia-associated hepatitis C virus infection. Br J Rheumatol. 1997;26:981-985.
22. Hsu VM, Patella SJ, Sigal LH. "Chronic lyme disease" as the incorrect diagnosis in patients with fibromyalgia. Arthritis Rheum. 1993;36:1493-1500.
23. Nash P, Chard M, Hazleman B. Chronic Coxsackie B infection mimicking primary fibromyalgia. J Rheumatol. 1989;16:1506-1508.
24. Leventhal LJ, Naides SJ, Freundlich B. Fibromyalgia and parvovirus infection. Arthritis Rheum. 1991;34:1319-1324.
25. Buchwald D, Goldenberg D, Sullivan J, Komaroff AL. The "chronic active Epstein-Barr virus infection" syndrome and primary fibromyalgia. Arthritis Rheum. 1987; 30:1132-1136.
26. Berg AM, Naides SJ, Simms RW. Established fibromyalgia syndrome and parvovirus B19 infection. J Rheumatol. 1993;20:1941-1943.
27. Ware JE, Sherbourne CD. The MOS 36-item Short-form Health Survey (SF-36). Med Care. 1992;30:473-483.
28. Derogatis LR. The SCL-90 Manual I: Scoring, Administration, and Procedure for the SCL-90. Baltimore, Md: Clinical Psychometrics Unit, Johns Hopkins University; 1977.
29. Barsky AJ, Goodson JD, Lane RS, Cleary PD. The amplification of somatic symptoms. Psychosom Med. 1988;50:510-519.
30. Lane RS, Barsky AJ, Goodson JD. Discomfort and disability in upper respiratory tract infection. J Gen Intern Med. 1988;3:540-546.
31. Procidano ME, Heller K. Measures of perceived support from friends and from family: three validating studies. Am J Community Psychol. 1983;44:1-24.
32. Brugha TS, Cragg D. The list of threatening life experiences, the reliability and validity of a brief life events questionnaire. Acta Psychiatr Scand. 1990;82: 77-81.
33. Wallston KA, Wallston BA, Devellis R. Development of the multidimensional health locus of control (MHLC) scales. Health Educ Monogr. 1978;6:160-170.
34. Eysenck HJ, Eysenck SBG. Manual of the Eysenck Personality Questionnaire. San Diego, Calif: Educational and Industrial Testing; 1972.
35. Totman R, Kiff J, Reed SE, Craig W. Predicting experimental colds in volunteers from different measures of recent life stress. J Psychosom Res. 1980;24:155-163.
36. Broadbent DE, Broadbent MHP, Phillpotts RJ, Wallace J. Some further studies on the prediction of experimental colds in volunteers by psychological factors. J Psychosom Res. 1984;28:511-523.
37. Folkman S, Lazarus RS. An analysis of coping in a middle-aged community sample. J Health Soc Behav. 1980;21:219-239.
38. Robins LN, Heizer JE. Diagnostic Interview Schedule Version IIIA. St Louis, Mo: Department of Psychiatry, Washington University School of Medicine; 1985.
39. Greenfield S, Fitzcharles MA, Esdaile JM. Reactive fibromyalgia syndrome. Arthritis Rhem. 1992;35:678-681.
40. Boisset Pioro MH, Esdaile JM, Fitzcharles MA. Sexual and physical abuse in women with fibromyalgia syndrome. Arthritis Rheum. 1995;38:235-241.
41. Aaron LA, Bradley LA, Alarcon GS, Triana-Alexander RW, Martin MY, Alberts KR. Perceived physical and emotional trauma as precipitating in fibromyalgia: associations with health care seeking and disability status but not pain severity. Arthritis Rheum. 1997;40:453-460.
42. Hudson JI, Goldenberg DL, Pope HG Jr, Keck PE Jr, Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med. 1992;92:363-367.
43. Duna GF, Wilke WS. Diagnosis, etiology, and therapy of fibromyalgia. Compr Ther. 1993;19:60-63.
44. Kreuger JM, Toth LA, Floyd R, et al. Sleep, microbes and cytokines. Neuroimmunomodulation. 1994;1:100-109.
45. Dunn AJ. Infection as a Stressor: acytokine-mediated activation of the hypothalamopituitary-adrenal axis? Ciba Found Symp. 1993;172:226-239.
46. Pollmacher T, Mullington J, Korth C, Hinze SD. Influence of host defense activation on sleep in humans. Adv Neuroimmunol. 1995;5:155-169.
47. Croft P, Schollum J, Silman A. Population study offender point counts and pain as evidence of fibromyalgia. BMJ. 1994;309:696-699.
48. Wolfe F. The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis. 1997;56:268-271.
49. Tsigos C, Papanicolaou DA, Defensor R, Mitsiadis CS, Kyrou I, Chrousos GP. Dose-effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Neuroendocrinology. 1997;66:54-62.
50. Chrousos GP. Integration of the immune and endocrine systems by interleukin-6. In: Papanicolaou DA, moderator. The Pathophysiologic Roles of Interleukin-6 in Human Disease. Ann Intern Med. 1998;128:127-137.
51. Makela M, Heliovaara M. Prevalence of primary fibromyalgia in the Finnish population. BMJ. 1991;303:216-219.
52. Wolfe F, Cathey MA. The epidemiology of tender points: a prospective study of 1520 patients. J Rheumatol. 1985;12:1164-1168.
53. Breenwood DC, Muir KR, Packham CJ, Madely RJ. Coronary heart disease: a review of the role of psychosocial stress and social support. J Public Health Med. 1996;18:221-231.
54. Spiegel D. Psychological aspects of breast cancer treatment. Semin Oncol. 1997; 24:36-47.
55. Talal AH, Drossman DA. Psychosocial factors in inflammatory bowel disease. Gastroenterol Clin North Am. 1995;24:699-716.
56. Wolfe F. Practical issues in psychosocial measures. J Rheumatol. 1997;24:990-993.
57. Bolwijn PH, van Santen-Hoeufft M, Baars H, van der Linden S. Social network characteristics in fibromyalgia or rheumatoid arthritis. Arthritis Care Res. 1994; 7:46-49.
58. Bolwijn PH, van Santen-Hoeufft M, Baars H, Kaplan CD, van der Linden S. The social network characteristics of fibromyalgia patients compared with healthy controls. Arthritis Care Res. 1996;9:18-26.
59. Gaston-Johansson F, Gustafsson M, Felldin R, Sanne H. A comparative study of feelings, attitudes, and behaviors of patients with fibromyalgia and rheumatoid arthritis. Soc Sci Med. 1990;31:941-947.
60. Payne TC, Leavitt F, Garron DC, et al. Fibrositis and psychologic disturbance. Arthritis Rheum. 1982;25:213-217.
61. Wolfe F, Cathey MA, Kleinheksel S. Psychological status in primary fibrositis and fibrositis associated with rheumatoid arthritis. J Rheumatol. 1984;11:505-506.
62. Norman SE, Chediak AD, Kiel M, Cohn M. Sleep disturbances in HIV-infected homosexual men. AIDS. 1990;4:775-781.
63. Reynolds CF. Sleep and affective disorders: a minireview. Sleep Disord. 1987; 10:583-591.